Trombly Amy Moss 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Dec 29, 2023
Insider Transaction Report
Form 4
Trombly Amy Moss
Chief Executive Officer
Transactions
- Award
Stock option (right to buy)
2023-12-29+60,000→ 173,648 totalExercise: $0.18Exp: 2033-12-29→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Ms. Trombly's employment agreement.
- [F2]The options were awarded and granted to Ms. Trombly for services performed as part of the Company's annual grant of stock options.